CELL AND GENE THERAPY INSIGHTS

February 2021 Issue

Volume 7 Issue 1

Cell and Gene Therapy Insights Volume 7 Issue 1
Download PDF

Featuring

Issue Spotlight: Preclinical/translational tools and strategies
Other articles
Webinars

SPOTLIGHT

Preclinical/translational tools and strategies
Bruce Bunnell
Guest Editor:
Bruce Bunnell, Professor and Chair at UNT Health Science Center

Foreword

Preclinical/translational tools & strategies

Preclinical/translational tools & strategies

Bruce A Bunnell
24 February 2021
Read

Editorial

Accelerating preclinical development for AAV based gene therapies: bridging the gap between discovery and clinical development

Accelerating preclinical development for AAV based gene therapies: bridging the gap between discovery and clinical development

Louise Rodino-Klapac
24 February 2021
Read

Expert Insight

The T cell therapy field faces preclinical and translational R&D challenges as it targets more complex diseases

The T cell therapy field faces preclinical and translational R&D challenges as it targets more complex diseases

G Waanders, S Raffegerst, P Prinz-Schulz et al.
15 February 2021
Read
Modelling late-onset diseases with induced pluripotent stem cells: a matter of time management

Modelling late-onset diseases with induced pluripotent stem cells: a matter of time management

Charlotte Cossins, Paul J Fairchild
15 February 2021
Read
Animal models of disease: preclinical to clinical gene therapy translatability

Animal models of disease: preclinical to clinical gene therapy translatability

Erika Matsumoto Plata, Carlos R Plata-Salamán
11 February 2021
Read

Commentary

Expediting novel ex vivo HSC gene therapies to the clinic: a preclinical perspective

Expediting novel ex vivo HSC gene therapies to the clinic: a preclinical perspective

G Leoni, A Lambert, C Hudson et al.
24 February 2021
Read

Interview

On a mission to bring single-cell sequencing to cell and gene therapy

On a mission to bring single-cell sequencing to cell and gene therapy

Charlie Silver
24 February 2021
Read
Beginning gene therapy preclinical development with the end in mind: from preclinical to economic modelling

Beginning gene therapy preclinical development with the end in mind: from preclinical to economic modelling

Olivier Negre, PhD
16 February 2021
Read

Podcast

On a mission to bring single-cell sequencing to cell and gene therapy

On a mission to bring single-cell sequencing to cell and gene therapy

24 February 2021
Listen

FastFacts

Identify and select optimal T cell phenotypes

Identify and select optimal T cell phenotypes

James Lovrgen
22 February 2021
Read

Journal articles

Expert Insight

Business Insight: cell & gene therapy

Business Insight: cell & gene therapy

J Mulryne, D Beatriz San Martin, J Schmidt et al.
1 February 2021
Read

Innovator Insight

Optimization of AAV process development: transfection matters

Optimization of AAV process development: transfection matters

K Wosnitzka, S Pariag, H Trottin et al.
14 January 2021
Read

Interview

A stepwise approach to process optimization in cellular immunotherapy development

A stepwise approach to process optimization in cellular immunotherapy development

Jim Lu
24 February 2021
Read
Get in line: developing in-process analytical tools for gene therapy applications

Get in line: developing in-process analytical tools for gene therapy applications

10 February 2021
Read

Podcast

Get in line: developing in-process analytical tools for gene therapy applications

Get in line: developing in-process analytical tools for gene therapy applications

René Gantier, Ramsey Shanbaky, Jay West
10 February 2021
Listen

FastFacts

The importance of a strong collection cell collection network during the COVID-19 pandemic

The importance of a strong collection cell collection network during the COVID-19 pandemic

Chris McClain, MBA
11 February 2021
Read

Translation Insight

Flow cytometric analysis for cellular therapy products: design and practical considerations

Flow cytometric analysis for cellular therapy products: design and practical considerations

Alison J Thomson, Laura Bailey, John DM Campbell
26 January 2021
Read

Webinars